Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
17.64
+0.93 (5.57%)
At close: Mar 9, 2026, 4:00 PM EDT
17.62
-0.02 (-0.11%)
After-hours: Mar 9, 2026, 7:50 PM EDT
Sarepta Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,852 | 2,255 | 11,614 | 9,021 | 11,375 | 7,841 | |
| Market Cap Growth | -82.12% | -80.58% | 28.75% | -20.70% | 45.06% | -41.72% | |
| Enterprise Value | 1,952 | 2,664 | 11,831 | 8,677 | 10,907 | 7,420 | |
| Last Close Price | 17.64 | 21.52 | 121.59 | 96.43 | 129.58 | 90.05 | |
| PE Ratio | - | - | 49.37 | - | - | - | |
| Forward PE | 5.60 | 90.12 | 15.47 | - | - | - | |
| PS Ratio | 0.84 | 1.03 | 6.11 | 7.26 | 12.19 | 11.17 | |
| PB Ratio | 1.62 | 1.98 | 7.60 | 10.50 | 29.55 | 8.45 | |
| P/TBV Ratio | 1.67 | 2.03 | 7.74 | 10.87 | 30.14 | 8.58 | |
| EV/Sales Ratio | 0.89 | 1.21 | 6.22 | 6.98 | 11.69 | 10.57 | |
| EV/EBITDA Ratio | - | - | 46.25 | - | - | - | |
| EV/EBIT Ratio | - | - | 54.25 | - | - | - | |
| Debt / Equity Ratio | 0.91 | 0.91 | 0.87 | 1.61 | 4.20 | 1.23 | |
| Debt / EBITDA Ratio | - | - | 3.70 | - | - | - | |
| Net Debt / Equity Ratio | 0.09 | 0.09 | -0.02 | -0.35 | -0.97 | -1.05 | |
| Net Debt / EBITDA Ratio | -0.16 | -0.16 | -0.10 | 1.33 | 0.75 | 2.41 | |
| Net Debt / FCF Ratio | -0.32 | -0.32 | 0.07 | 0.52 | 1.04 | 2.03 | |
| Asset Turnover | 0.60 | 0.60 | 0.53 | 0.39 | 0.30 | 0.23 | |
| Inventory Turnover | 2.84 | 2.84 | 2.10 | 3.90 | 5.21 | 4.12 | |
| Quick Ratio | 1.33 | 1.33 | 2.74 | 3.23 | 3.63 | 5.05 | |
| Current Ratio | 2.32 | 2.32 | 4.20 | 3.95 | 4.13 | 5.75 | |
| Return on Equity (ROE) | -53.47% | -53.47% | 19.71% | -86.15% | -107.16% | -49.57% | |
| Return on Assets (ROA) | -11.24% | -11.24% | 3.77% | -5.24% | -10.68% | -9.04% | |
| Return on Invested Capital (ROIC) | -44.29% | -47.96% | 19.06% | -93.16% | - | - | |
| Return on Capital Employed (ROCE) | -29.20% | -29.20% | 6.70% | -10.30% | -21.40% | -16.50% | |
| Earnings Yield | -38.52% | -31.64% | 2.02% | -5.94% | -6.19% | -5.34% | |
| FCF Yield | -16.60% | -13.63% | -2.95% | -6.40% | -3.13% | -6.14% | |
| Buyback Yield / Dilution | 7.19% | 7.19% | -16.75% | -5.53% | -7.75% | -4.24% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.